As of 2025-06-26, the Fair Value of Syros Pharmaceuticals Inc (SYRS) is -93.28 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.12 USD, the upside of Syros Pharmaceuticals Inc is -79,693.85%.
With the market price of 0.12 USD and our fair value calculation, Syros Pharmaceuticals Inc (SYRS) is not a good investment. Investing in SYRS stocks now will result in a potential loss of 79,693.85%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -75.44 | -84.04 | -86.56 | -94.65 | -164.57 | -101.05 |
| YoY growth | -21.13% | -11.40% | -3.00% | -9.35% | -73.88% | -23.75% |
| Market Cap (mil) | 0.61 |
| P/E | |
| Forward P/E |
| EPS | -18.66 |
| Avg earnings growth rate | -23.75% |
| TTM earnings | -97.81 |